Thomas Kislinger, PhD

The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research. 
Eur J Neurol. 2014 Aug 7;
Wallin MT, Oh U, Nyalwidhe J, Semmes J, Kislinger T, Coffman P, Kurtzke JF, Jacobson S
Cell Rep. 2014 Mar 13;6(5):892-905
Kim HS, Mukhopadhyay R, Rothbart SB, Silva AC, Vanoosthuyse V, Radovani E, Kislinger T, Roguev A, Ryan CJ, Xu J, Jahari H, Hardwick KG, Greenblatt JF, Krogan NJ, Fillingham JS, Strahl BD, Bouhassira EE, Edelmann W, Keogh MC
Expert Rev Proteomics. 2014 Apr;11(2):167-77
Drake RR, Kislinger T
Proteomics. 2014 Mar;14(6):795-803
Zhang W, Wei Y, Ignatchenko V, Li L, Sakashita S, Pham NA, Taylor P, Tsao MS, Kislinger T, Moran MF
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701
Sinha A, Ignatchenko V, Ignatchenko A, Mejia-Guerrero S, Kislinger T
Exp Cell Res. 2013 Oct 15;319(17):2747-57
Garnier D, Magnus N, Meehan B, Kislinger T, Rak J
Proteomics. 2013 May;13(10-11):1667-71
Principe S, Jones EE, Kim Y, Sinha A, Nyalwidhe JO, Brooks J, Semmes OJ, Troyer DA, Lance RS, Kislinger T, Drake RR
Proteomics. 2013 May;13(10-11):1608-23
Principe S, Hui AB, Bruce J, Sinha A, Liu FF, Kislinger T

Pages